Approvals/TGA/OMJJARA momelotinib (as dihydrochloride monohydrate) 200 mg film-coated tablet bottle

Approved

STANDARD

OMJJARA momelotinib (as dihydrochloride monohydrate) 200 mg film-coated tablet bottle

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d433c299359a3e52
Product Name: OMJJARA momelotinib (as dihydrochloride monohydrate) 200 mg film-coated tablet bottle
Artg Id: 442232
Artg Name: OMJJARA momelotinib (as dihydrochloride monohydrate) 200 mg film-coated tablet bottle
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2024-12-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/507a1d93a85d5f9165a596b103784ee2.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b72e140c5898c61ef33f2e485228901a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

d433c299359a3e52

Type

Standard